IGFBP2 Drives Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via Activating the Wnt/β-Catenin Pathway

Researchers presented evidence highlighting the influence exerted by insulin-like growth factor-binding protein 2 (IGFBP2) as a potent oncogene driving the malignant phenotype.